Cuijuan Zhang

Prof. Cuijuan Zhang


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in Gynecologic Oncology
Verified
Journal Article
Closed access
YSYan Sheng
Yan Sheng
HWHongtao Wang
Hongtao Wang
DLDongchen Liu
Dongchen Liu
CZCheng Zhang
Cheng Zhang
YDYupeng Deng
Yupeng Deng
CZCuijuan Zhang
Cuijuan Zhang

30 April 2019 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Closed access
PDF file
CZCheng Zhang
Cheng Zhang
SGShuang Ge
Shuang Ge
JWJun Wang
Jun Wang
XJXiaotong Jing
Xiaotong Jing
HLHailing Li
Hailing Li
CZCuijuan Zhang
Cuijuan Zhang

7 August 2023 in The Journal of Pathology
Verified
Journal Article
Open access
YFYawei Feng
Yawei Feng
SWShiguan Wang
Shiguan Wang
JXJianjun Xie
Jianjun Xie
BDBin Ding
Bin Ding
MWMin Wang
Min Wang
CZCuijuan Zhang
Cuijuan Zhang
Granulomatous slack skin (GSS) is an extremely rare subtype of cutaneous T‐cell lymphoma accompanied by an abundant number of macrophages and is clinically characterized by the development of pendulous skin folds. However, the characteristics of these macrophages in GSS remain unclear. Here, we conducted a spatial transcriptomic study on one frozen GSS sample and drew transcriptomic maps of GSS for the first time. Gene expression analysis revealed the enrichment of three clusters with macrophage transcripts, each exhibiting distinct characteristics suggesting that their primary composition consists of different subpopulations of macrophages. The CD163+/CD206+ cluster showed a tumor‐associated macrophage (TAM) M2‐like phenotype and highly expressed ZFP36, CCL2, TNFAIP6, and KLF2, which are known to be involved in T‐cell interaction and tumor progression. The APOC1+/APOE+ cluster presented a non‐M1 or ‐M2 phenotype and may be related to lipid metabolism. The CD11c+/LYZ+ cluster exhibited an M1‐like phenotype. Notably, these cells strongly expressed MMP9, MMP12, CHI3L1, CHIT1, COL1A1, TIMP1, and SPP1, which are responsible for extracellular matrix (ECM) degradation and tissue remodeling. This may partially explain the symptoms of cutaneous relaxation in GSS. Further immunohistochemistry on four GSS cases demonstrated that CD11c predominantly marked granulomas and multinucleated giant cells, whereas CD163 was mainly expressed on scattered macrophages, appearing as a mutually exclusive pattern. The expression pattern of MMP9 overlapped with that of CD11c, implying that CD11c+ macrophages may be a source of MMP9. Our data shed light on the characteristics of macrophages in the GSS microenvironment and provide a theoretical basis for the application of MMP9 inhibitors to prevent cutaneous relaxation of GSS. © 2023 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

6 December 2022 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
YCYing-Tai Chen
Ying-Tai Chen
JYJianhua Yin
Jianhua Yin
LZLulu Zhao
Lulu Zhao
GZGuangyu Zhou
Guangyu Zhou
SDShichen Dong
Shichen Dong
DZDongbing Zhao
Dongbing Zhao
Background: Little is known on the tumor microenvironment (TME) response after neoadjuvant chemotherapy (NACT) in gastric cancer on the molecular level. Methods: Here, we profiled 33,589 cell transcriptomes in 14 samples from 11 gastric cancer patients (4 pre-treatment samples, 4 post-treatment samples and 3 pre-post pairs) using single-cell RNA sequencing (scRNA-seq) to generate the cell atlas. The ligand-receptor-based intercellular communication networks of the single cells were also characterized before and after NACT. Results: Compered to pre-treatment samples, CD4+ T cells (P = 0.018) and CD8+ T cells (P = 0.010) of post-treatment samples were significantly decreased, while endothelial cells and fibroblasts were increased (P = 0.034 and P = 0.005, respectively). No significant difference observed with respect to CD4+ Tregs cells, cycling T cells, B cells, plasma cells, macrophages, monocytes, dendritic cells, and mast cells (P > 0.05). In the unsupervised nonnegative matrix factorization (NMF) analysis, we revealed that there were three transcriptional programs (NMF1, NMF2 and NMF3) shared among these samples. Compared to pre-treatment samples, signature score of NMF1 was significantly downregulated after treatment (P = 0.009), while the NMF2 signature was significantly upregulated after treatment (P = 0.013). The downregulated NMF1 and upregulated NMF2 signatures were both associated with improved overall survival outcomes based on The Cancer Genome Atlas (TCGA) database. Additionally, proangiogenic pathways were activated in tumor and endothelial cells after treatment, indicating that NACT triggers vascular remodeling by cancer cells together with stromal cells. Conclusions: In conclusion, our study provided transcriptional profiles of TME between pre-treatment and post-treatment for in-depth understanding on the mechanisms of NACT in gastric cancer and empowering the development of potential optimized therapy procedures and novel drugs.

1 January 2015 in Journal of Cancer
Verified
Journal Article
Open access
HCHaiyan Chen
Haiyan Chen
TZTingguo Zhang
Tingguo Zhang
YSYan Sheng
Yan Sheng
CZCheng Zhang
Cheng Zhang
YPYunfei Peng
Yunfei Peng
CZCuijuan Zhang
Cuijuan Zhang
DNA methylation is considered as a significant mechanism that silences tumor suppressor genes (TSGs) and could be used in the early diagnosis of cancer. Histone modifications often work together with DNA methylation; however, how these epigenetic alterations regulate TSGs remains unclear. Here, we determined the methylation status of ten TSGs (3OST2, ppENK, CHFR, LKB1, THBS1, HIC1, SLIT2, EDNRB, COX2, and CLDN7) in hepatocellular carcinoma (HCC) and corresponding noncancerous tissues. Methylation profiling revealed that four genes had very high frequencies of methylation in HCCs, but interestingly, similar high frequencies were also detected in corresponding noncancerous tissues (97.9% vs 95.8% for SLIT2, 93.8% vs 81.3% for EDNRB, 66.7% vs 85.4% for HIC1, and 56.3% vs 56.3% for ppENK, P > 0.05). Only the 3OST2 gene was frequently methylated in HCCs and there was significant difference between HCCs and corresponding noncancerous tissues (68.8% vs 37.5%, P < 0.05). 5-aza-2'-deoxycytidine (5-Aza-CdR) or trichostatin A (TSA) alone could partially reverse 3OST2 methylation, and their combination resulted in complete reversal. UHRF1 and histone H3R8me2s were both enriched on the hypermethylated 3OST2 promoter, but H3R8me2a was not. After 5-Aza-CdR or TSA treatment, the UHRF1 and H3R8me2s enrichment was decreased, while H3R8me2a enrichment increased. We demonstrated that 3OST2 methylation may play a critical role in the earliest steps of hepatocarcinogenesis and is directly regulated by UHRF1. Furthermore, H3R8me2s acted as a repressive mark, while H3R8me2a was correlated with 3OST2 transcriptional activity.

1 January 2016 in Journal of Cancer
Verified
Journal Article
Open access
CZCheng Zhang
Cheng Zhang
YPYunfei Peng
Yunfei Peng
FYFan Yang
Fan Yang
RQRuixi Qin
Ruixi Qin
WLWenjun Liu
Wenjun Liu
CZCuijuan Zhang
Cuijuan Zhang
AIM: Protocadherin-8 (PCDH8) plays an important role in signaling pathways of cell adhesin, proliferation, and migration. It has been reported that PCDH8 is mutated or methylated in several human cancers. However, little is known about PCDH8 in liver cancer. The aim of this study was to investigate the protein expression and promoter methylation status of PCDH8 in liver cancer and evaluate the association between PCDH8 methylation and the clinicopathological features.